Comparison between use of combination of mifepristone and misoprostol versus misoprostol alone in the management of intrauterine fetal death
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20182880Keywords:
Delivery interval, Intrauterine fetal death, Induction, Misoprostol, MifepristoneAbstract
Background: Intrauterine fetal death (IUFD) is estimated to occur in 1% of all pregnancies. The advent of prostaglandins has revolutionized the management of IUFD. There are limited studies using a combined regimen of mifepristone and misoprost for induction of labor in IUFD. Hence this study was undertaken to assess the efficacy and safety of combined regimen with misoprostol alone, in the management of IUFD.
Methods: This hospital based prospective study included 60 pregnant women with IUFD admitted at Mediciti Institute of Medical Sciences, during the period January 2015 to July 2016. An ultrasound scan was performed to confirm IUFD and localize the placenta. Women were divided alternatively into 2 groups with 30 in each group (group 1- women received 200 mg mifepristone orally followed by misoprostol after 24 hours & in group 2, 100 µg misoprostol every 6 hourly for a maximum of 4 doses between gestational age 24-26 weeks, 25-50 µg 4 hourly for a maximum of 6 doses beyond 26 weeks).
Results: The mean induction to delivery interval was 10 hours in group 1 and 16.3 hours in group 2 (p value 0.007). Mean dose of misoprostol required in group 1 was 1.87 and 2.67 in group 2 (p value 0.008). With respect to side effects, the two groups did not differ significantly.
Conclusions: The combined regimen was more effective than misoprostol for the induction of labour in IUFD, in terms of higher rate of successful delivery and shorter induction to delivery interval.
References
Chittacharoen A. A randomized trial of oral & vaginal misoprostol to manage delivery in cases of fetal death obsetgynaecol. 2003;101(1):70-3.
ACOG practice bulletin No.102: Management of stillbirth. Obstet Gynecol. 2009;113:748-61.
Dutta DC. Preterm labour, preterm rupture of the membranes, post maturity, Intrauterine death of fetus. In: Konar H, editor. Text book of obstetrics including perinatology and contraception. 6th ed. Vol.21. Calcutta: New Central Book Agency (P) Ltd; 2004: 314-326.
ParasnisH, Raje B, Hinduja IN. Relevance of plasma fibrinogen estimation in obstetric complications. J Post grad Med. 1992;38:183-5.
Pritchard JA. Fetal death in utero. Obstet Gynecol. 1959;14:573-80.
Kochenour NK. Management of fetal demise. Clin Obstet Gynecol. 1987;30(2):322-30.
Fletcher HM, Wharfe G, Simeon D, Mitchell S, Brown D. Induction of labor with intravainal misoprostol versus dinoprostone in intrauterine death: a retrospective study. J Obstet Gynaecol. 1996;16:155-8
Ngai SW, Tang OS, Ho PC. Prostaglandins for induction of second – trimester termination and intrauterine death. Best Pract Res Clin Obstet Gynecol. 2003;17(5):765-75.
Loose DS, Stancel GM. Estrogens and progestins. In: Goodman & Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw Hill; 2006: 1541-1572.
Jang GR, Benet LZ. Antiprogestin pharmacodynamics, pharmacokinetics and metabolism: implications for their long term use. J Pharmacokinet Biopharm. 1997;25:647-72.
Robbins A, Splitz IM. Mifepristone: Clinical pharmacology. Clin Obstet Gynecol. 1996;39(2):436-50.
Ngoc NT, Shochet T, Raghavan S, Blum J, Nga NT, Minh NT, et al. Mifepristone and misoprostol compared with misoprostol alone for second- trimester abortion: A randomized controlled trial. Obstet Gynecol. 2011;118:601-8.
Nagaria T, Sirmor N. Misoprostol vs mifepristone and misoprostol in second trimester termination of pregnancy. J Obstet Gynecol India. 2011;61:659-62.
Ashok PW, Flett GM, Templeton A. Effective, low-cost regimens for medical termination of pregnancy at all gestations. Contemp Rev Obstet Gynaecol. 1999;11:207-12.
Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod. 1998;13(10):2962-5.
Chaudhuri P. Mandal A, Das C, Mazumdar A. Dosing interval of 24 hours versus 48 hours between mifepristone and misoprostol administration for mid trimester termination of pregnancy. Int J Gynaecol Obstet. 2014;124:134-8.
Fairley TE, Mackenzie M, Owen P, Mackenzie F. Management of late intrauterine death using a combination of Mifepristone and misoprostol experience of two regimens. Eur J ObstetGyn RB. 2005;118:28-31.
Gupta S, Kagathra B, Desai A. Mifepristone and misoprostol versus group2 in management of late intrauterine fetal death. Int J Reprod Contracept Obstet Gynecol. 2016;5(9):293.
Wagaarachchi PT, Ashok PW, Narvekar NN, Smith NC, Templeton A. Medical management of late intrauterine death using a combination of mifepristone and misoprostol. Br J ObstetGynaecol. 2002;109:443-7.
